These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8140754)

  • 1. [Present status of treatment of opportunistic mycotic infections with systemic antimycotics].
    Háber J; Kolesková E; Straub J; Klener P
    Vnitr Lek; 1994 Jan; 40(1):59-64. PubMed ID: 8140754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antimycotic therapy].
    Schaffner A
    Ther Umsch; 1990 Aug; 47(8):664-9. PubMed ID: 2218968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [New aspects in treatment of systemic mycoses].
    Presterl E; Graninger W
    Wien Klin Wochenschr; 1998 Nov; 110(21):740-50. PubMed ID: 9871965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prevention, diagnosis and therapy of infections in patients with malignant diseases].
    Hiddemann W; Maschmeyer G; Runde V; Einsele H
    Internist (Berl); 1996 Dec; 37(12):1212-24. PubMed ID: 9081922
    [No Abstract]   [Full Text] [Related]  

  • 5. [Diagnosis, prevention and therapy of systemic mycoses within the scope of surgical intensive care].
    Tausch W; Tausch I; Ziegler-Böhme H
    Zentralbl Chir; 1989; 114(13):876-82. PubMed ID: 2678827
    [No Abstract]   [Full Text] [Related]  

  • 6. Itraconazole: managing mycotic complications in immunocompromised patients.
    Graybill JR
    Semin Oncol; 1998 Jun; 25(3 Suppl 7):58-63. PubMed ID: 9671333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opportunistic mycoses--some priorities for the 90s.
    Smith JM
    N Z Med J; 1991 Oct; 104(921):420. PubMed ID: 1923092
    [No Abstract]   [Full Text] [Related]  

  • 8. Antifungal therapy in the immunocompromised host.
    Meunier F
    Mykosen Suppl; 1988; 2():54-8. PubMed ID: 3078024
    [No Abstract]   [Full Text] [Related]  

  • 9. Combination therapy with antifungal drugs.
    Polak A
    Mykosen Suppl; 1988; 2():45-53. PubMed ID: 3078023
    [No Abstract]   [Full Text] [Related]  

  • 10. Practice guidelines for the treatment of fungal infections. For the Mycoses Study Group. Infectious Diseases Society of America.
    Sobel JD
    Clin Infect Dis; 2000 Apr; 30(4):652. PubMed ID: 10770725
    [No Abstract]   [Full Text] [Related]  

  • 11. [Current topics in mycology].
    Khan M; Plempel M; Wassilew SW
    Z Hautkr; 1989 Oct; 64(10):837-8, 841-2. PubMed ID: 2686240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapeutic safety of antimycotics in the treatment of systemic fungal infections].
    Fehér J; Lengyel G
    Orv Hetil; 2003 Aug; 144(34):1677-82. PubMed ID: 14528841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fungi fighting back.
    Environ Health Perspect; 1997 Jan; 105(1):26-7. PubMed ID: 9074874
    [No Abstract]   [Full Text] [Related]  

  • 14. [Therapy of invasive organ mycoses in patients with systemic hematologic diseases].
    Karthaus M; Böhme A
    Wien Med Wochenschr; 2001; 151(3-4):80-8. PubMed ID: 11789423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Is it possible to prevent mycotic infections in oncology patients?].
    Mayer J; Vorlícek J
    Vnitr Lek; 1994 Dec; 40(12):783-8. PubMed ID: 7839633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevention of mycotic infections in oncology patients with regard to the toxicity of antimycotic agents].
    Doubek M; Mayer J; Horký D; Doubek J; Rácil Z; Vorlícek J
    Vnitr Lek; 2002 Mar; 48(3):248-54. PubMed ID: 11968587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antifungal resistance in opportunistic pathogenic fungi (I). Polyenes and fluorocytosine].
    Martínez-Suárez JV; Rodríguez-Tudela JL
    Enferm Infecc Microbiol Clin; 1996; 14(6):384-9. PubMed ID: 8756218
    [No Abstract]   [Full Text] [Related]  

  • 18. Recombinant interferon gamma1b immune enhancement in 20 patients with hematologic malignancies and systemic opportunistic infections treated with donor granulocyte transfusions.
    Safdar A; Rodriguez GH; Lichtiger B; Dickey BF; Kontoyiannis DP; Freireich EJ; Shpall EJ; Raad II; Kantarjian HM; Champlin RE
    Cancer; 2006 Jun; 106(12):2664-71. PubMed ID: 16691620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Present status and perspectives on antimycotics with systemic effects].
    Haber J
    Cas Lek Cesk; 2001 Sep; 140(19):596-604. PubMed ID: 11715729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antifungal agents and immunomodulators in systemic mycoses.
    Khan ZK; Jain P
    Indian J Chest Dis Allied Sci; 2000; 42(4):345-55. PubMed ID: 15597684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.